Travere Therapeutics, Inc. (TVTX)
49.60
-3.19
(-6.04%)
USD |
NASDAQ |
Oct 16, 16:00
49.62
+0.02
(+0.04%)
After-Hours: 20:00
Travere Therapeutics Net Income (TTM) : -67.68M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -67.68M |
| March 31, 2026 | -45.64M |
| December 31, 2025 | -50.26M |
| September 30, 2025 | -88.54M |
| June 30, 2025 | -169.00M |
| March 31, 2025 | -225.90M |
| December 31, 2024 | -320.63M |
| September 30, 2024 | -348.96M |
| June 30, 2024 | -383.45M |
| March 31, 2024 | -399.42M |
| December 31, 2023 | -360.03M |
| September 30, 2023 | -357.07M |
| June 30, 2023 | -351.89M |
| March 31, 2023 | -333.30M |
| December 31, 2022 | -312.70M |
| September 30, 2022 | -278.64M |
| June 30, 2022 | -230.22M |
| March 31, 2022 | -202.20M |
| December 31, 2021 | -180.09M |
| September 30, 2021 | -250.14M |
| June 30, 2021 | -237.05M |
| March 31, 2021 | -224.11M |
| December 31, 2020 | -169.43M |
| September 30, 2020 | -78.07M |
| June 30, 2020 | -92.01M |
| Date | Value |
|---|---|
| March 31, 2020 | -104.64M |
| December 31, 2019 | -146.43M |
| September 30, 2019 | -123.62M |
| June 30, 2019 | -141.65M |
| March 31, 2019 | -125.28M |
| December 31, 2018 | -102.68M |
| September 30, 2018 | -112.84M |
| June 30, 2018 | -76.12M |
| March 31, 2018 | -67.02M |
| December 31, 2017 | -59.73M |
| September 30, 2017 | -50.72M |
| June 30, 2017 | -70.04M |
| March 31, 2017 | -70.21M |
| December 31, 2016 | -47.90M |
| September 30, 2016 | -41.77M |
| June 30, 2016 | 100.92M |
| March 31, 2016 | 88.80M |
| December 31, 2015 | 117.24M |
| September 30, 2015 | 90.68M |
| June 30, 2015 | -34.46M |
| March 31, 2015 | -0.4455M |
| December 31, 2014 | -110.73M |
| September 30, 2014 | -94.52M |
| June 30, 2014 | -85.86M |
| March 31, 2014 | -99.39M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| TG Therapeutics, Inc. | 441.49M |
| BioMarin Pharmaceutical, Inc. | 72.97M |
| Vertex Pharmaceuticals, Inc. | 4.405B |
| Viridian Therapeutics, Inc. | -368.60M |
| Krystal Biotech, Inc. | 241.46M |